Metraipolis › archive › dc_1d5767f563cb

Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis — Europe PMC PMID:41613318

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41613318
DOI
10.3389/fmed.2025.1739284
License (as archived)
solo-consultazione
Archived
2026-11-06T20:06:11.769Z
SHA-256 of the archived text
5548111306e63876d09babf06bc034b3d881fb94d16f89e5c2138e4fd666c8c8
Stable URL of this page
https://metraipolis.com/documento/dc_1d5767f563cb

How to cite

Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis — Europe PMC PMID:41613318 — Europe PMC (en), https://europepmc.org/article/MED/41613318 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1d5767f563cb (Metraipolis archive dc_1d5767f563cb, sha256 5548111306e63876d09babf06bc034b3d881fb94d16f89e5c2138e4fd666c8c8)
BibTeX
@misc{dc1d5767f563cb,
  title = {Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis — Europe PMC PMID:41613318},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41613318},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1d5767f563cb; sha256 5548111306e63876d09babf06bc034b3d881fb94d16f89e5c2138e4fd666c8c8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41613318. Agents can read the archived copy with the MCP tool read_document.